HOME  |  CONTACT  
  spi2012  
 
sachs associates   6th ANNUAL
EUROPEAN LIFE SCIENCE CEO FORUM PARTNERING & INVESTING
in Biotech & Pharma Industry
    5th – 6th March 2013 • Hilton Zurich Airport Hotel, Switzerland
 
  spi2012  
 
 
Register Now
 
Register
To Exhibit
 
Register
To Present
 
sachs sachs sachs sachs sachs sachs sachs
Biotech i Europe Investor Forum
 
sachs sachs
 
 
PRESENTING COMPANIES AT
6th ANNUAL FORUM INCLUDE:

Ability Pharmaceuticals
AKRIKHIN OJSC
Amakem N.V.
Anergis
Antisense Pharma GmbH
APIM Therapeutics AS
Apogenix GmbH
B Cell Design
Biomay AG
Biotie Therapies Corp
BONESUPPORT AB
Bone Therapeutics SA
CellMed
Ciloa, SAS
Colby Pharmaceutical Company
Covagen AG
Cristal Delivery B.V.
Cureline, Inc
DOMAIN THERAPEUTICS
Dualsystems Biotech AG
Ennar Pharma
Epigenomics AG
ERA Biotech S.A.
Glycotope
GRL Inc
Helsinn Healthcare SA
HemaCore LLC
Heptares Therapeutics Ltd
immatics biotechologies
IMMUNE Pharmaceuticals
Immunovaccine Inc
Implandata Opthalmic Products GmbH
Insuline-Medical Ltd
i-Optics
Juventas Therapeutics, Inc.
KLOX Technologies
Lipopharma
Mabimmune Diagnostics AG
MedGenesis Therapeutix Inc
NeuroPhage Pharmaceuticals
Numab AG
OBS Medical
Opexa Therapeutics, Inc.
Opsona Therapeutics Ltd
Palobiofarma S.L
ProteoMediX AG
Resverlogix Corp
R-Pharm
Scancell Holdings Plc.
Serpin Pharma
Synthena AG
Synthon BV
TELORMEDIX SA
TheraKine Ltd
TN LLC
uniQure B.V.
UroTiss GmbH
Vaccibody AS
Vifor Pharma Ltd
ViroGates
Virometix d

 

 

About 6th Annual European Life Sciences CEO Forum

The 6th Annual European Life Sciences CEO Forum, is being held on 5th-6th March 2013 at the Hilton Zurich Airport Hotel, Switzerland. This event will be highly transactional, bringing together an exciting cross-section of venture-funded and small-cap companies with leading investors, pharmas, and scientific thought leaders. We expect around 350 delegates and 80 presenting companies. Information about the last year’s event is available on the event’s website here.


The programme will comprise of Plenary panels with confirmed chairs including:

MAIN PANELS TO COVER:

Public Markets and M&A chaired by:
Stephanie Leouzon, Senior Advisor, Torreya Partners

Investment chaired by:
Regina Hodits, General Partner, Wellington Partners
Thomas Stockman, Director Healtcare Investment Banking, Citi Group

Partnering chaired by:
Fintan Walton, CEO and Founder, PharmaVentures

SPECIALIST PANELS INCLUDE:

MedTech & Device chaired by:
Markus Hosang, General Partner, BioMedPartners AG

Neuroscience chaired by:
Lubor Gaal, Head of Europe, Strategic Transactions Group, BMS
Saira Ramasastry, Managing Partner, Life Science Advisory, LLC

Oncology & Diagnostics chaired by:
Christina Takke, Partner, Forbion Captial Partners
Chris Britten, Independent Consultant

Platform Technologies & Novel Therapeutics chaired by:
Esteban Pombo Villar, Chief Operations Officer, Oxford BioTherapeutics
Katya Smirnyagina, Venture Partner, Capricorn Venture Partners

Regenerative Medicine chaired by:
Lorenza Castellon, Health and Biotech Equity Analyst, Equity Development

Vaccines chaired by:
Florian Schodel, CEO, Philimmune LLC

NEW FOR 2013

Israel Panel chaired by:
Laurent Choppe, Managing Partner, Life Sciences, Cukierman and Co.
Featuring
Einat Zisman, CEO, Hadasit Medical Research Services & Development Ltd.
Daniel Teper, CEO, Immune Pharma
Ora Dar, Head of the Life Sciences, Office of the Chief Scientist,
Ministry of Industry, Trade and Labor, Israel
Tomer Kariv, Co-Founder and CEO, Pontifax Corp.

RUSSIAN BIO-MED
      Venture Investment Panel chaired by:
      Alexey Eliseev, Managing Director, Maxwell Biotech Venture Fund

      Featuring
      Chris Janssen, Director of Science and Innovation, Biomedical Cluster,
      Skolkovo Foundation
      Olga Potapova, CEO, Cureline
      Igor Pivovarov, CEO, HemaCore
      Others - TBA

      Pharma Partners and Investment Opportunities Panel chaired by:
      Irena Melnikova, Managing Director Russia, Burrill & Company
      Featuring
      Julia Sardaryan, Head of Business Development, OCT Clinical Trials
      Rustam Ixanov, Vice-President of Strategic Development,
      AKRIKHIN Pharmaceuticals Co.
      Vasily Ignatiev, CEO, R-Pharm
      Others - TBA

Emerging Companies Panel chaired by:
Peter Burckhardt, CEO, EVA – the Basel life sciences start-up agency
Featuring
Søren Møller, Managing Investment Director, Novo Seeds

...and more to be announced later

See our Confirmed Speakers and Chairs >>>


Presenting Opportunities

Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business.

Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.

The forum is recognised as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners.

Sponsorship

Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.

Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.

To learn more about presenting, exhibition or sponsorship opportunities, please contact
Zoe Harris + 44 (0)203 463 4890 or by email: Zoe Harris.

 
Conference Guide:
Click the cover below to download the full conference guide.
Sachs Confernce Guide
  Pharma Licensing
  Groups represented
  at the Forum include:
AstraZeneca Bristol-Meyers Squibb Helsinn Menarini Merck Serono Novartis F.Hoffmann-La Roche Ltd Les Laboratories Servier
 
  Meeting Scheduler
1-2-1 Meeting system
 

 

 
  Sponsors & Supporters